Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News TNF Pharmaceuticals Inc TNFA

Healthcare
TNF Pharmaceuticals, Inc., formerly MyMD Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company focused on developing novel therapies for age-related diseases and autoimmune and inflammatory conditions. It is focused on developing and commercializing two therapeutic platforms based on well-defined therapeutic targets: MYMD-1 and Supera-CBD. MYMD-1 is a drug platform based on a... see more

Recent & Breaking News (NDAQ:TNFA)

Earnings Scheduled For April 3, 2018

Benzinga.com  April 3, 2018

Akers Biosciences Announces Rescheduled Conference Call to Discuss Fiscal Year 2017 Earnings

GlobeNewswire March 28, 2018

17 Stocks Moving In Monday's Pre-Market Session

Benzinga.com  March 26, 2018

Akers Biosciences Signs US Distribution Agreement with Diagnostica Stago

GlobeNewswire March 26, 2018

Akers Biosciences Announces Conference Call to Discuss Fiscal Year 2017 Earnings

GlobeNewswire March 15, 2018

Akers Biosciences Announces Closing of $6,900,000 Public Offering

GlobeNewswire December 21, 2017

Akers Biosciences Prices $6,000,000 Public Offering

GlobeNewswire December 18, 2017

Akers Biosciences Secures Further Intellectual Property Protection for Akers Wellness Line

GlobeNewswire December 8, 2017

Akers Biosciences, Inc. to Host Earnings Call

Accesswire November 15, 2017

Akers Biosciences Announces Q3 2017 Earnings

GlobeNewswire November 15, 2017

Akers Biosciences’ UK Distributor Secures New Channel for Rapid Alcohol Breathalyzer

GlobeNewswire November 14, 2017

Akers Biosciences Announces Conference Call to Discuss Q3 2017 Earnings

GlobeNewswire November 13, 2017

Akers Biosciences Hires Medical Device Specialist to Lead US Sales and Distribution

Marketwired September 7, 2017

Investor Network: Akers Biosciences, Inc. to Host Earnings Call

Accesswire August 15, 2017

Akers Biosciences Announces Q2 2017 Earnings

Marketwired August 15, 2017

Akers Biosciences Announces Board Changes

Marketwired August 8, 2017

Akers Biosciences Announces Second Quarter Trading Update

Marketwired August 3, 2017

Investor Network: Akers Biosciences, Inc. to Host Earnings Call

Accesswire May 16, 2017

Akers Biosciences Announces Q1 2017 Earnings

Marketwired May 16, 2017

Akers Biosciences Announces Conference Call to Discuss Q1 2017 Earnings

Marketwired May 12, 2017